Standard & Poor's Equity Research raised the price target on Alcon to $131 from $106 and said the ophthalmic medical technology company remains set for continued sales growth on the strength of new products...

Take 1 minute to subscribe and you'll get this story, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in Orange County
  • NEW: Orange County 500 — influential business leaders you need to know
Yours for only $99.

Click Here for more information and subscription form.